Literature DB >> 28867228

Chitosan-titanium dioxide-glucantime nanoassemblies effects on promastigote and amastigote of Leishmania major.

Jaleh Varshosaz1, Bahar Arbabi2, Nader Pestehchian3, Sedigheh Saberi4, Mahdi Delavari5.   

Abstract

The purpose of the present study was to design nanoassemblies of chitosan-titanium dioxide (TiO2) nanoparticles (NPs) loaded with glucantime for using their synergistic effects and enhancing the toxic effects of glucantime on Leishmania parasites. The nanoassemblies were prepared by electrostatic interactions and optimized by a response surface central composite design. The effects of glucantime, chitosan and TiO2 NPs amounts were studied on the particle size, zeta potential, loading efficiency, and release efficiency of drug from nanoassemblies. The conjugation of TiO2/chitosan-glucantime was verified by UV spectroscopy and changes in surface charge of NPs. The anti-promastigots effect of glucantime loaded in TiO2/chitosan nanoassemblies was studied by tripan blue dye test and their anti-amastigotes effect by counting the average number of parasites per infected J774 macrophages in 100 cells. The optimized formulation obtained by using 12.5mg glucantime, 25mg chitosan and 6mg TiO2 NPs. Although TiO2 NPs alone were effective more than negative control in reduction of promastigots and amastigotes but they didn't show significant difference compared with free glucantime (p>0.05). However, at the concentration of 50μg/mL and after 72h exposure nanoassemblies decreased the proliferation of L. major promastigotes and amastigotes 13 and 4-fold, respectively compared with glucantime alone.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amastigote; Chitosan; Glucantime; Leishmania major; Promastigote; Titanium dioxide nanoparticles

Mesh:

Substances:

Year:  2017        PMID: 28867228     DOI: 10.1016/j.ijbiomac.2017.08.177

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  10 in total

Review 1.  Nanotechnology based solutions for anti-leishmanial impediments: a detailed insight.

Authors:  Humzah Jamshaid; Fakhar Ud Din; Gul Majid Khan
Journal:  J Nanobiotechnology       Date:  2021-04-15       Impact factor: 10.435

2.  Critical Antileishmanial in vitro Effects of Highly Examined Gold Nanoparticles.

Authors:  Muzamil Yaqub Want; Priya Yadav; Rakin Khan; Garima Chouhan; Mohammad Islamuddin; Sheka Yagub Aloyouni; Asoke P Chattopadhyay; Suliman Yousef AlOmar; Farhat Afrin
Journal:  Int J Nanomedicine       Date:  2021-10-28

3.  The Designing of a Gel Formulation with Chitosan Polymer Using Liposomes as Nanocarriers of Amphotericin B for a Non-invasive Treatment Model of Cutaneous Leishmaniasis.

Authors:  Nergiz Gürbüz Çolak; Emel Öykü Çetin Uyanikgil; Yusuf Özbel; Seray Töz
Journal:  Acta Parasitol       Date:  2022-07-20       Impact factor: 1.534

Review 4.  Effect of chitosan on Toxoplasma gondii infection: A systematic review.

Authors:  Kourosh Cheraghipour; Leila Masoori; Fatemeh Ezzatkhah; Iraj Salimikia; Sana Amiri; Ali Safar Makenali; Farshad Taherpour; Hossein Mahmoudvand
Journal:  Parasite Epidemiol Control       Date:  2020-10-21

5.  Nanomedicine-based strategies to improve treatment of cutaneous leishmaniasis.

Authors:  Nowsheen Goonoo; Marie Andrea Laetitia Huët; Itisha Chummun; Nancy Karuri; Kingsley Badu; Fanny Gimié; Jonas Bergrath; Margit Schulze; Mareike Müller; Archana Bhaw-Luximon
Journal:  R Soc Open Sci       Date:  2022-06-15       Impact factor: 3.653

6.  Therapeutic effects of Lucilia sericata larval excretion/secretion products on Leishmania major under in vitro and in vivo conditions.

Authors:  Jila Sherafati; Mohammad Saaid Dayer; Fatemeh Ghaffarifar
Journal:  Parasit Vectors       Date:  2022-06-16       Impact factor: 4.047

Review 7.  Applications of Nanomaterials in Leishmaniasis: A Focus on Recent Advances and Challenges.

Authors:  Kiran Saleem; Zainab Khursheed; Christophe Hano; Iram Anjum; Sumaira Anjum
Journal:  Nanomaterials (Basel)       Date:  2019-12-09       Impact factor: 5.076

Review 8.  Chitosan Contribution to Therapeutic and Vaccinal Approaches for the Control of Leishmaniasis.

Authors:  Philippe M Loiseau; Sébastien Pomel; Simon L Croft
Journal:  Molecules       Date:  2020-09-09       Impact factor: 4.411

Review 9.  Chitosan-Based Nanomaterials as Valuable Sources of Anti-Leishmanial Agents: A Systematic Review.

Authors:  Hamdan I AlMohammed; Amal Khudair Khalaf; Aishah E Albalawi; Abdullah D Alanazi; Parastoo Baharvand; Ali Moghaddam; Hossein Mahmoudvand
Journal:  Nanomaterials (Basel)       Date:  2021-03-10       Impact factor: 5.076

10.  Synthesis and Biological Evaluation of Tetrahydropyrimidine and Dihydropyridine Derivatives Against Leishmania Major.

Authors:  Behnaz Jeddi; Sedigheh Saberi; J Carlos Menéndez; Saghi Sepehri
Journal:  Acta Parasitol       Date:  2021-07-19       Impact factor: 1.440

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.